72
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Loss of miR-516a-3p mediates upregulation of ABCC5 in prostate cancer and drives its progression

, , , &
Pages 3853-3867 | Published online: 06 Jul 2018

References

  • SiegelRMillerKJemalAStatisticsCCA Cancer J Clin2015201563529
  • FukudaYSchuetzJDABC transporters and their role in nucleoside and nucleotide drug resistanceBiochem Pharmacol20128381073108322285911
  • PrattSShepardRLKandasamyRAJohnstonPAPerryWDantzigAHThe multidrug resistance protein 5 (ABCC5) confers resistance to 5-fluorouracil and transports its monophosphorylated metabolitesMol Cancer Ther20054585586315897250
  • ParkSShimizuCShimoyamaTGene expression profiling of ATP-binding cassette (ABC) transporters as a predictor of the pathologic response to neoadjuvant chemotherapy in breast cancer patientsBreast Cancer Res Treat200699191716752223
  • FletcherJIHaberMHendersonMJNorrisMDABC transporters in cancer: more than just drug efflux pumpsNat Rev Cancer201010214715620075923
  • LiBChenHWuNZhangWJShangLXDeregulation of miR-128 in ovarian cancer promotes cisplatin resistanceInt J Gynecol Cancer20142481381138825248111
  • HamamotoJYasudaHAizawaKNon-small cell lung cancer PC-9 cells exhibit increased sensitivity to gemcitabine and vinorelbine upon acquiring resistance to EGFR-tyrosine kinase inhibitorsOncol Lett20171433559356528927112
  • MourskaiaAAAmirEDongZABCC5 supports osteoclast formation and promotes breast cancer metastasis to boneBreast Cancer Res2012146R14923174366
  • BushatiNCohenSMmicroRNA functionsAnnu Rev Cell Dev Biol20072317520517506695
  • CarthewRWSontheimerEJOrigins and mechanisms of miRNAs and siRNAsCell2009136464265519239886
  • LiHYangBBStress response of glioblastoma cells mediated by miR-17-5p targeting PTEN and the passenger strand miR-17-3p targeting MDM2Oncotarget20123121653166823391506
  • ZhangHLiSYangXQiaoBZhangZXuYmiR-539 inhibits prostate cancer progression by directly targeting SPAG5J Exp Clin Cancer Res2016356027037000
  • ZhangHQiCWangAPrognostication of prostate cancer based on NUCB2 protein assessment: NUCB2 in prostate cancerJ Exp Clin Cancer Res2013327724422979
  • KimJYuWKovalskiKOssowskiLRequirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assayCell19989433533629708737
  • ArredouaniMSLuBBhasinMIdentification of the transcription factor single-minded homologue 2 as a potential biomarker and immunotherapy target in prostate cancerClin Cancer Res200915185794580219737960
  • GrassoCSWuYMRobinsonDRThe mutational landscape of lethal castration-resistant prostate cancerNature2012487740623924322722839
  • LuoJHYuYPCieplyKGene expression analysis of prostate cancersMol Carcinog2002331253511807955
  • TomlinsSAMehraRRhodesDRIntegrative molecular concept modeling of prostate cancer progressionNat Genet2007391415117173048
  • WallaceTAPrueittRLYiMTumor immunobiological differences in prostate cancer between African-American and European-American menCancer Res200868392793618245496
  • ChandranURMaCDhirRGene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic processBMC Cancer200776417430594
  • HolzbeierleinJLalPLatulippeEGene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistanceAm J Pathol2004164121722714695335
  • VaramballySYuJLaxmanBIntegrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progressionCancer Cell20058539340616286247
  • YuYPLandsittelDJingLGene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancyJ Clin Oncol200422142790279915254046
  • LapointeJLiCHigginsJPGene expression profiling identifies clinically relevant subtypes of prostate cancerProc Natl Acad Sci U S A2004101381181614711987
  • LatulippeESatagopanJSmithAComprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic diseaseCancer Res200262154499450612154061
  • TaylorBSSchultzNHieronymusHIntegrative genomic profiling of human prostate cancerCancer Cell2010181112220579941
  • NakagawaTKollmeyerTMMorlanBWA tissue biomarker panel predicting systemic progression after PSA recurrence post-definitive prostate cancer therapyPLoS One200835e231818846227
  • SinghDFebboPGRossKGene expression correlates of clinical prostate cancer behaviorCancer Cell20021220320912086878
  • VanajaDKChevilleJCIturriaSJYoungCYTranscriptional silencing of zinc finger protein 185 identified by expression profiling is associated with prostate cancer progressionCancer Res200363143877388212873976
  • WelshJBSapinosoLMSuAIAnalysis of gene expression identifies candidate markers and pharmacological targets in prostate cancerCancer Res200161165974597811507037
  • TakeiYTakigahiraMMiharaKTarumiYYanagiharaKThe metastasis-associated microRNA miR-516a-3p is a novel therapeutic target for inhibiting peritoneal dissemination of human scirrhous gastric cancerCancer Res20117141442145321169410
  • SpahnMKneitzSScholzCJExpression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrenceInt J Cancer2010127239440319585579
  • LeungAKSharpPAMicroRNA functions in stress responsesMol Cell201040220521520965416